The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma

Dizdarevic, S.; Tulchinsky, M.; McCready, V.R.; Mihailovic, J,; Vinjamuri, S.; Buscombe, J.R.; Lee, S.T.; Frangos, S.; Sathekge, Mike Machaba; Siraj, Q.; Choudhury, P.; Bom, H.; Franceschi, M.; Ugrinska, A.; Paez, D.; Hussain, R.; Mailman, J.; Luster, M.; Virgolini, I.

The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma

Dizdarevic, S.; Tulchinsky, M.; McCready, V.R.; Mihailovic, J,; Vinjamuri, S.; Buscombe, J.R.; Lee, S.T.; Frangos, S.; Sathekge, Mike Machaba; Siraj, Q.; Choudhury, P.; Bom, H.; Franceschi, M.; Ugrinska, A.; Paez, D.; Hussain, R.; Mailman, J.; Luster, M.; Virgolini, I.

URI: http://hdl.handle.net/2263/76135

Date: 2019-04

Abstract:

The World Association of Radiopharmaceutical and Molecular Therapy (WARMTH) is a worldwide nonprofit organization, which is dedicated to educating medical professionals in the use of radionuclide therapies based on the theragnostic principles and to harmonizing appropriate evidence‑based practices worldwide.

Show full item record